SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246,762 | -27.3% | 71,113 | -2.6% | 0.02% | +33.3% |
| Q2 2023 | $339,380 | +0.6% | 72,985 | 0.0% | 0.01% | +50.0% |
| Q1 2023 | $337,191 | -45.8% | 72,985 | -5.3% | 0.01% | -27.3% |
| Q4 2022 | $622,677 | +132.3% | 77,064 | +328.4% | 0.01% | +57.1% |
| Q4 2021 | $268,000 | -61.9% | 17,988 | -51.7% | 0.01% | -46.2% |
| Q3 2021 | $703,000 | -21.5% | 37,235 | -22.7% | 0.01% | -18.8% |
| Q2 2021 | $896,000 | -22.8% | 48,186 | -5.4% | 0.02% | -20.0% |
| Q1 2021 | $1,160,000 | -16.1% | 50,949 | -19.9% | 0.02% | -20.0% |
| Q4 2020 | $1,382,000 | +226.7% | 63,646 | +51.1% | 0.02% | +92.3% |
| Q3 2020 | $423,000 | – | 42,130 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |